Functioning envelope protein intermediates as HIV vaccine targets

被引:0
作者
Nunberg, JH [1 ]
机构
[1] Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA
来源
RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES | 2000年
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:9 / 11
页数:3
相关论文
共 10 条
[1]   JITTERS JEOPARDIZE AIDS VACCINE TRIALS [J].
COHEN, J .
SCIENCE, 1993, 262 (5136) :980-981
[2]   Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines [J].
Connor, RI ;
Korber, BTM ;
Graham, BS ;
Hahn, BH ;
Ho, DD ;
Walker, BD ;
Neumann, AU ;
Vermund, SH ;
Mestecky, J ;
Jackson, S ;
Fenamore, E ;
Cao, Y ;
Gao, F ;
Kalams, S ;
Kunstman, KJ ;
McDonald, D ;
McWilliams, N ;
Trkola, A ;
Moore, JP ;
Wolinsky, SM .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1552-1576
[3]   Capture of an early fusion-active conformation of HIV-1 gp41 [J].
Furuta, RA ;
Wild, CT ;
Weng, YK ;
Weiss, CD .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (04) :276-279
[4]   Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity [J].
LaCasse, RA ;
Follis, KE ;
Moudgil, T ;
Trahey, M ;
Binley, JM ;
Planelles, V ;
Zolla-Pazner, S ;
Nunberg, JH .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2491-2495
[5]   RETRACTED: Fusion-competent vaccines broad neutralization of primary isolates of HIV (Retracted article. See vol 296, pg 1025, 2002) [J].
LaCasse, RA ;
Follis, KE ;
Trahey, M ;
Scarborough, JD ;
Littman, DR ;
Nunberg, JH .
SCIENCE, 1999, 283 (5400) :357-362
[6]   Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay [J].
Mascola, JR ;
Louder, MK ;
Surman, SR ;
Vancott, TC ;
Yu, XF ;
Bradac, J ;
Porter, KR ;
Nelson, KE ;
Girard, M ;
McNeil, JG ;
McCutchan, FE ;
Birx, DL ;
Burke, DS .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (14) :1319-1328
[7]  
Montefiori David C., 1999, AIDS Research and Human Retroviruses, V15, P689, DOI 10.1089/088922299310773
[8]   Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes [J].
Moore, JP ;
Cao, YZ ;
Leu, J ;
Qin, LM ;
Korber, B ;
Ho, DD .
JOURNAL OF VIROLOGY, 1996, 70 (01) :427-444
[9]   Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope [J].
VanCott, TC ;
Mascola, JR ;
Loomis-Price, LD ;
Sinangil, F ;
Zitomersky, N ;
McNeil, J ;
Robb, ML ;
Birx, DL ;
Barnett, S .
JOURNAL OF VIROLOGY, 1999, 73 (06) :4640-4650
[10]   Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype [J].
Weber, J ;
Fenyo, EM ;
Beddows, S ;
Kaleebu, P ;
Bjorndal, A ;
Osmanov, S ;
Heyward, W ;
Esparza, J ;
GalvaoCastro, B ;
vandePerre, P ;
Karita, E ;
Wasi, C ;
Sempala, S ;
Tugume, B ;
Biryahwaho, B ;
RubsamenWaigmann, H ;
vonBriesen, H ;
Esser, R ;
Grez, M ;
Holmes, H ;
Newberry, A ;
Ranjbar, S ;
Tomlinson, P ;
Bradac, J ;
McCutchan, F ;
Louwagie, J ;
Hegerich, P ;
LopezGalindez, C ;
Olivares, I ;
Dopazo, J ;
Mullins, JI ;
Delwart, EL ;
Bachmann, HM ;
Goudsmit, J ;
deWolf, F ;
Hahn, BH ;
Gao, F ;
Yue, L ;
Saragosti, S ;
Schochetman, G ;
Kalish, M ;
Luo, CC ;
George, R ;
Pau, CP ;
CheingsongPopov, R ;
Nara, P ;
Albert, J ;
Myers, G ;
Korber, B .
JOURNAL OF VIROLOGY, 1996, 70 (11) :7827-7832